Govt Job: For M.Pharm, M.Sc as Senior Research Fellow in AIIMS

All-India Institute of Medical Sciences (AIIMS) was established as an institution of national importance by an Act of Parliament with the object to develop patterns of teaching Undergraduate and Post-graduate Medical Education in all its branches so as to demonstrate a high standard of Medical Education in India;

  • To bring together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity
  • To attain self-sufficiency in Post-graduate Medical Education.

Post: Senior Research Fellow (SRF)

Applications are invited for the post of Senior Research Fellow (SRF) in an ICMR-funded project (Project code: 1-1331) entitled “Genetic expression of monoaminergic neurotransmission related polymorphisms and their association with antidepressant response in Indian patients suffering from depression.” with a project duration of 3 years.

Minimum Qualifications: M.Sc, (Life Sciences / Pharmacology) degree holders with two years of research experience.

OR MBBS/BDS/ M.Pharm. degree holders Desirable qualification:

Experience in qRT-PCR-based techniques and clinical studies
Monthly emoluments: Rs. 35,000/- pm+ HRA permissible as per rule

Age Limit: Up to 35 years

Interested candidates are required to submit their applications with a CV by email to “neuropharmalab5002@gmail.com” or directly at 5th Floor, Room No. 5002, Convergence Block, Department of Pharmacology, AIIMS, New Delhi.

The shortlisted candidate will be informed about the date and venue of the interview by email of the telephone call.

The last date for submission of applications is October 25th, 2022.

Related Posts

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad